This content is machine translated ESC Guideline 2023 on ACS What is new in antithrombotic therapy? The clinical presentation of acute coronary syndrome (ACS) is broad and ranges from asymptomatic to persistent chest discomfort to cardiac arrest, electrical/hemodynamic instability and cardiogenic shock. The European Society of…
View Post 8 min This content is machine translated Percutaneous coronary intervention (PCI) Benefits of complete revascularization in elderly patients The benefit of complete revascularization in older patients (≥75 years) with myocardial infarction and multivessel disease is still unclear. At the ESC Congress, however, the results of the FIRE study…
View Post 5 min This content is machine translated Acute coronary syndrome Recommendations of the new ESC guidelines Clinically, acute coronary syndrome (ACS) is typically manifested by pectanginal chest pain, occasionally associated with vegetative symptoms. While STEMI requires rapid invasive coronary diagnosis and reperfusion, in NSTEMI the approach…
View Post 3 min This content is machine translated Acute coronary syndrome In case of ST-segment elevations in the ECG, immediate revascularization is indicated! Thoracic pain is a common reason for consultation in the family practice. If an acute coronary syndrome is suspected, the ECG findings, in addition to the clinical presentation and troponin…
View Post 8 min This content is machine translated Percutaneous coronary intervention How to post-treat after PCI? The type and duration of combined antithrombotic therapy vary. Decisive factors are the clinical setting (stable CHD vs. ACS), the need for additional anticoagulation (e.g., atrial fibrillation), and the patient-specific…
View Post 8 min This content is machine translated 40 years of percutaneous coronary intervention Update on indications, outcomes, and concomitant drug therapy. With PCI, mortality in acute coronary syndrome has been impressively reduced. An overview of current technical developments (stents), key treatment guidelines, and adjunctive therapies. Includes overview interventional vs surgical treatment…
View Post 15 min This content is machine translated Platelet aggregation inhibition in PCI. “The flow must go on” Inhibition of coagulation is an important cornerstone of therapy for acute coronary syndrome. For this purpose, platelet aggregation inhibitors targeting thromboxane synthesis, the ADP receptor, the glycoprotein receptor IIb/IIIa and…
View Post 7 min This content is machine translated ESC Congress in London Much discussed results on myocardial infarction and pacemakers. Once again this year, numerous exciting events took place at the ESC Congress in London. As always, the hot-line sessions with cutting-edge and practice-relevant study results generated a lot of…
View Post 6 min This content is machine translated Highlights from the AHA Congress 2014 What insights did IMPROVE-IT and DAPT bring? The American Heart Association conference in Chicago drew attention primarily for two long-awaited study updates. At this point, the most important results from the IMPROVE-IT and DAPT studies will be…
